CD340 Recombinant Protein

Description of CD340 Recombinant Protein

General information on CD340 Recombinant Protein

Structure of CD340

CD340 is a biomarker protein composed of a single polypeptide chain.

Activity of CD340

CD340 is involved in the metabolism of xenobiotics and endogenous compounds. It is capable of oxidizing a wide range of substrates, including steroids, fatty acids, and aromatic compounds.

Applications of CD340

CD340 has been used in research as an antibody-drug target for cancer therapy. It has also been studied as a potential biomarker for the diagnosis and prognosis of various types of cancer. Additionally, CD340 has been explored as a target for drug development and drug delivery.

CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay

Immobilized CD340 Recombinant Protein (cat. No. PX-P4121) at 0.5µg/mL (100µL/well) can bind Trastuzumab Biosimilar - Anti-HER2 mAb (cat. No. PX-TA1005) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 662.9M.

CD340 Recombinant Protein binds to Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb in indirect ELISA assay

Immobilized CD340 Recombinant Protein (cat. No. PX-P4121) at 0.5µg/mL (100µL/well) can bind Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb (cat. No. PX-TA1058) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 9.566M.